DermBiont
MA - Boston
Biotechnology1 H-1B visas (FY2023)Focus: Topical Bacterial Products
DermBiont is a life sciences company focused on Topical Bacterial Products.
ImmunologyOncologyInfectious Diseases
Open Jobs
0
Pipeline & Clinical Trials
Swab
Covid19Clinical Trials (1)
NCT04668911Oral Health, Microbial Burden and COVID-19
N/ACohort 1 J. Lividum
Interdigital Tinea PedisClinical Trials (1)
NCT04315051A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis
Phase 2J. lividum
Atopic DermatitisClinical Trials (1)
NCT04192513Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo
Phase 2Janthinobacterium lividum
Tinea PedisClinical Trials (1)
NCT04152226A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis
Phase 2SM-020 1% Gel
Non-Melanoma Skin CancersClinical Trials (1)
NCT06409195A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers
Phase 2DBI-102
HyperpigmentationClinical Trials (1)
NCT05511948Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos
Phase 2DBI-001
OnychomycosisClinical Trials (1)
NCT05491603A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis
Phase 2SM-020 gel 1.0%
Seborrheic KeratosisClinical Trials (1)
NCT06108024A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
Phase 2SM-020 gel 1.0%
Dermatosis Papulosa NigraClinical Trials (1)
NCT06099080A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)
Phase 2SM-020
Seborrheic KeratosisClinical Trials (1)
NCT05136144Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis
Phase 2SM-030 gel 0.64%
MelasmaClinical Trials (1)
NCT06454747Randomized Study Using SM-030 Gel for Adults With Melasma
Phase 2DBI-001
Atopic DermatitisClinical Trials (1)
NCT05253755Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel
Phase 2DBI-002 probiotic gel
Tinea VersicolorClinical Trials (1)
NCT04937920A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor
Phase 2DBI-001 Gel
Tinea PedisClinical Trials (1)
NCT05493488A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 14 clinical trials
H-1B (2023): 1 approval
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub